603139.SH
Shaanxi Kanghui Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 31.81
+1.56%Oct 9, 2026, 06:24 UTC
Kanghui Co., Ltd. established Xi'an Kanghui Zhichuang Technology Co., Ltd., a wholly owned subsidiary whose business scope includes software development, AI software development, AI industry application system integration, and data processing and storage support.
Source:Sep 24, 2026, 09:33 UTC
Kanghui Pharmaceutical's controlling subsidiary Shaanxi Youbang Biomedical Technology received approval from the Weinan Intermediate People's Court to extend its pre-restructuring period by one month.
Source:Sep 1, 2026, 13:20 UTC
Shanghai Chuangxiangying Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5% of Kanghui Co., completed its share reduction plan, selling 998,800 shares via centralized bidding from July 16 to August 31, 2026, reducing its stake from above 5% to 4.69%.
Source:Aug 28, 2026, 10:41 UTC
Kanghui Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 9.0925 million yuan, turning from a loss in the same period of 2025.
Source: